TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.

Ronan J Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.